Obligation IBRD-Global 0.9% ( US459058JC89 ) en USD

IBRD-Global

100 % ▲

Etas-Unis

US459058JC89 ( en USD )

0.9% par an ( paiement semestriel )

14/05/2030

Prospectus brochure de l'obligation IBRD US459058JC89 en USD 0.9%, échéance 14/05/2030

1 000 USD

4 000 000 000 USD

459058JC8

14/11/2025 ( Dans 136 jours )

La Banque internationale pour la reconstruction et le développement (IBRD), membre du Groupe de la Banque mondiale, fournit des prêts et des services consultatifs aux pays à revenu intermédiaire et à revenu faible pour soutenir leur développement économique.

L'Obligation émise par IBRD-Global ( Etas-Unis ) , en USD, avec le code ISIN US459058JC89, paye un coupon de 0.9% par an.
Le paiement des coupons est semestriel et la maturité de l'Obligation est le 14/05/2030

EXECUTION VERSION

Final Terms dated May 12, 2020

International Bank for Reconstruction and Development

Issue of US$4,000,000,000 0.875 per cent. Notes due May 14, 2030

under the
Global Debt Issuance Facility
Terms used herein shall be deemed to be defined as such for the purposes of the terms and
conditions (the "Conditions") set forth in the Prospectus dated May 28, 2008. This document constitutes
the Final Terms of the Notes described herein and must be read in conjunction with such Prospectus.
MiFID II product governance / Retail investors, professional investors and ECPs target
markets See Term 28 below.
SUMMARY OF THE NOTES
1. Issuer:
International Bank for Reconstruction and Development
("IBRD")
2. (i) Series Number:
101155
(ii) Tranche Number:
1
3. Specified Currency or Currencies
United States Dollars ("US$")
(Condition 1(d)):
4. Aggregate Nominal Amount:

(i) Series:
US$4,000,000,000
(ii) Tranche:
US$4,000,000,000
5. (i) Issue Price:
99.428 per cent. of the Aggregate Nominal Amount
(ii) Net proceeds:
US$3,970,120,000
6. Specified Denominations
US$1,000 and integral multiples thereof
(Condition 1(b)):
7. Issue Date:
May 14, 2020
8. Maturity Date (Condition 6(a)):
May 14, 2030
9. Interest Basis (Condition 5):
0.875 per cent. Fixed Rate
(further particulars specified below)
10. Redemption/Payment Basis
Redemption at par
(Condition 6):
11. Change of Interest or
Not Applicable
Redemption/Payment Basis:
12. Call/Put Options (Condition 6):
Not Applicable
13. Status of the Notes (Condition 3):
Unsecured and unsubordinated
14. Listing:
Luxembourg Stock Exchange
15. Method of distribution:
Syndicated

DC_LAN01:383879.2

PROVISIONS RELATING TO INTEREST (IF ANY) PAYABLE
16. Fixed Rate Note Provisions
Applicable
(Condition 5(a)):
(i)
Rate of Interest:
0.875 per cent. per annum payable semi-annually in arrear
(ii) Interest Payment Date(s):
May 14 and November 14 of each year, from and
including November 14, 2020, to and including the
Maturity Date, not subject to adjustment in accordance
with a Business Day Convention
(iii) Interest Period Date(s):
Each Interest Payment Date
(iv) Business Day Convention:
Not Applicable
(v) Fixed Coupon Amount(s):
US$4.38 per minimum Specified Denomination
(vi) Day Count Fraction
30/360
(Condition 5(l)):
(vii) Other terms relating to the
Not Applicable
method of calculating interest
for Fixed Rate Notes:
PROVISIONS RELATING TO REDEMPTION
17. Final Redemption Amount of each
US$1,000 per minimum Specified Denomination
Note (Condition 6):
18. Early Redemption Amount
As set out in the Conditions
(Condition 6(c)):
GENERAL PROVISIONS APPLICABLE TO THE NOTES
19. Form of Notes (Condition 1(a)):
Fed Bookentry Notes:

Fed Bookentry Notes available on Issue Date
20. New Global Note:
No
21. Financial Centre(s) or other special
New York
provisions relating to payment dates
(Condition 7(h)):
22. Governing law (Condition 14):
New York
23. Other final terms:
Not Applicable

-2-

DC_LAN01:383879.2

DISTRIBUTION
24. (i) If syndicated, names of
J.P. Morgan Securities plc:
US$957,250,000.00
Managers and
Merrill Lynch International:
US$957,250,000.00
underwriting
Nomura International plc:
US$957,250,000.00
commitments:
RBC Capital Markets, LLC:
US$957,250,000.00

BMO Capital Markets Corp.:
US$80,000,000.00
Deutsche Bank AG, London
US$28,000,000.00
Branch:
Morgan Stanley & Co. International
US$4,000,000.00
plc:
Wells Fargo Securities, LLC:
US$39,000,000.00

Barclays Bank PLC:
US$2,000,000.00
BNP Paribas:
US$2,000,000.00
CastleOak Securities, L.P.:
US$2,000,000.00
Citigroup Global Markets Limited:
US$2,000,000.00
Goldman Sachs International:
US$2,000,000.00
HSBC Bank plc:
US$2,000,000.00
Jefferies International Limited:
US$2,000,000.00
NatWest Markets Plc:
US$2,000,000.00
Skandinaviska Enskilda Banken AB US$2,000,000.00
(publ):
The Toronto-Dominion Bank:
US$2,000,000.00

(ii) Stabilizing Manager(s)
Not Applicable
(if any):
25. If non-syndicated, name of
Not Applicable
Dealer:
26. Total commission and
0.175 per cent. of the Aggregate Nominal Amount
concession:
27. Additional selling restrictions:
Not Applicable
28. MiFID II product governance
Directive 2014/65/EU (as amended, "MiFID II") product
Retail investors, professional
governance / Retail investors, professional investors and
investors and ECPs target
eligible counterparties ("ECPs") target market
markets:
Solely for the purposes of the manufacturers' product approval
process, the target market assessment in respect of the Notes has
led to the conclusion that: (i) the target market for the Notes is
eligible counterparties and professional and retail clients, each
as defined in MiFID II; and (ii) all channels for distribution of
the Notes are appropriate. Any person subsequently offering,
selling or recommending the Notes (a "distributor") should take
into consideration the manufacturers' target market assessment;
however, a distributor subject to MiFID II is responsible for
undertaking its own target market assessment in respect of the
Notes (by either adopting or refining the manufacturers' target

-3-

DC_LAN01:383879.2

market assessment) and determining appropriate distribution
channels.
IBRD does not fall under the scope of application of the MiFID
II package. Consequently, IBRD does not qualify as an
"investment firm", "manufacturer" or "distributor" for the
purposes of MiFID II.
For the purposes of this provision, the term "manufacturers"
means J.P. Morgan Securities plc, Merrill Lynch International
and Nomura International plc.
OPERATIONAL INFORMATION
29. ISIN Code:
US459058JC89
30. CUSIP:
459058JC8
31. Common Code:
217445329
32. Any clearing system(s) other
Bookentry system of the Federal Reserve Banks; Euroclear
than Euroclear Bank SA/NV,
Bank SA/NV; Clearstream Banking S.A.
Clearstream Banking S.A. and
The Depository Trust
Company and the relevant
identification number(s):
33. Delivery:
Delivery against payment
34. Intended to be held in a
Not Applicable
manner which would allow

Eurosystem eligibility:
GENERAL INFORMATION
IBRD's most recent Information Statement was issued on September 24, 2019.
USE OF PROCEEDS
Supporting sustainable development in IBRD's member countries

The net proceeds from the sale of the Notes will be used by IBRD to finance sustainable
development projects and programs in IBRD's member countries (without being committed or
earmarked for lending to, or financing of, any particular projects or programs). Prior to use, the net
proceeds will be invested by IBRD's Treasury in accordance with IBRD's liquid asset management
investment policies. IBRD's financing is made available solely to middle-income and creditworthy
lower-income member countries who are working in partnership with IBRD to eliminate extreme
poverty and boost shared prosperity, so that they can achieve equitable and sustainable economic
growth in their national economies and find sustainable solutions to pressing regional and global
economic and environmental problems. Projects and programs supported by IBRD are designed to
achieve a positive social impact and undergo a rigorous review and internal approval process aimed at
safeguarding equitable and sustainable economic growth.
IBRD integrates the following five global themes into its lending activities helping its borrowing
members create sustainable development solutions: climate change; gender; infrastructure, public-
private partnerships and guarantees; knowledge management; and fragility, conflict and violence.
IBRD's administrative and operating expenses are covered entirely by IBRD's various sources of
revenue (net income) consisting primarily of interest margin, equity contribution and investment
income (as more fully described in the Information Statement).

-4-

DC_LAN01:383879.2

SUPPLEMENTAL PROSPECTUS INFORMATION
Dealers are represented by Sullivan & Cromwell LLP. From time to time Sullivan & Cromwell LLP
performs legal services for IBRD.
Recent Developments
In light of the coronavirus disease ("COVID-19"), IBRD faces additional credit, market and
operational risks for its financial activities. IBRD continues to monitor the developments and to manage the
risks associated with all its portfolios.
In March 2020, in response to the global outbreak of COVID-19 and to support global public goods,
as part of a World Bank Group package, IBRD announced that it could deploy an estimated range of $50-$55
billion over the next 15 months to support member countries in their efforts to contain the pandemic and
respond to its immediate health consequences as well as address the social and economic effects. Given the
continued uncertainty around the outbreak's full impact on markets, as well as on client needs, these estimates
are subject to revisions. IBRD's response to the outbreak is within its existing financial, operational and risk
management policies as well as prescribed limits, which have not been modified as a result of the planned
response to the outbreak.
As of March 31, 2020, IBRD has sufficient resources to meet its liquidity requirements and continues
to have access to capital market resources, despite recent market volatility. In April 2020, IBRD raised $15
billion, including the largest ever U.S. dollar benchmark of $8 billion. IBRD continues to maintain a robust
liquidity position and flexibility to access the necessary liquidity resources. Management remains vigilant in
assessing funding needs in the medium and longer-term to manage the effect of severe market movements.
As of March 31, 2020, country credit risk and counterparty credit risk remain in line with the existing
governance framework and established credit limits. Developments in the market continue to be closely
monitored and managed.
As of March 31, 2020, home-based work has been invoked in all IBRD offices throughout the world,
with certain exceptions, in line with IBRD's Business Continuity Procedure. In addition, IBRD has adopted
other prudent measures to ensure the health and safety of its employees, including imposing travel restrictions,
rescheduling public events or holding them in virtual format. IBRD operations remain functional, even with
these changes in working arrangements.
The duration of the COVID-19 pandemic and its effects are difficult to predict at this time. The length
and severity of these developments as well as the impact on the financial results and condition of IBRD in
future periods cannot be reasonably estimated at this point in time. IBRD continues to monitor the situation
closely and will continue to manage the associated risks within its existing financial, operational and risk
management policies as well as prescribed limits.

SUPPLEMENTAL U.S. FEDERAL INCOME TAX CONSIDERATIONS
You should carefully consider the matters set forth under "Tax Matters" in the accompanying
Prospectus. The following discussion supplements the section "Tax Matters" in the accompanying Prospectus
and is subject to the limitations and exceptions set forth therein. The following section applies to you only if
you are a U.S. Holder (as defined in the accompanying Prospectus), you acquire your Notes on the issue date
and you hold your Notes as a capital asset for tax purposes.
You should consult with your own tax advisor concerning the consequences of investing in and
holding the Notes in your particular circumstances, including the application of state, local or other tax
laws and the possible effects of changes in federal or other tax laws.
Upon a sale or retirement of the Notes, a U.S. Holder will generally recognize capital gain or loss
equal to the difference, if any, between (i) the amount realized on the sale or retirement (other than amounts
attributable to accrued but unpaid interest, which would be treated as such) and (ii) the U.S. Holder's adjusted
tax basis in the Notes. A U.S. Holder's adjusted tax basis in the Notes generally will equal the cost of the

-5-

DC_LAN01:383879.2

Notes to the U.S. Holder. Capital gain of individual taxpayers from the sale or retirement of the Notes held for
more than one year may be eligible for reduced rates of taxation. The deductibility of a capital loss is subject
to significant limitations.
Information with Respect to Foreign Financial Assets. Owners of "specified foreign financial assets"
with an aggregate value in excess of US$50,000 (and in some circumstances, a higher threshold) may be
required to file an information report with respect to such assets with their tax returns. "Specified foreign
financial assets" may include financial accounts maintained by foreign financial institutions (which may
include the Notes), as well as the following, but only if they are held for investment and not held in accounts
maintained by financial institutions: (i) stocks and securities issued by non-U.S. persons, (ii) financial
instruments and contracts that have non-U.S. issuers or counterparties, and (iii) interests in foreign entities.
Holders should consult their tax advisors regarding the application of this reporting obligation to their
ownership of the Notes.
Medicare Tax. A U.S. Holder that is an individual or estate, or a trust that does not fall into a special
class of trusts that is exempt from such tax, is subject to a 3.8% tax (the "Medicare tax") on the lesser of (1)
the U.S. Holder's "net investment income" (or "undistributed net investment income" in the case of an estate
or trust) for the relevant taxable year and (2) the excess of the U.S. Holder's modified adjusted gross income
for the taxable year over a certain threshold (which in the case of individuals is between US$125,000 and
US$250,000, depending on the individual's circumstances). A U.S. Holder's net investment income will
generally include its gross interest income and its net gains from the disposition of Notes, unless such interest
payments or net gains are derived in the ordinary course of the conduct of a trade or business (other than a
trade or business that consists of certain passive or trading activities). If you are a U.S. Holder that is an
individual, estate or trust, you are urged to consult your tax advisors regarding the applicability of the
Medicare tax to your income and gains in respect of your investment in the Notes.
LISTING APPLICATION
These Final Terms comprise the final terms required for the admission to the Official List of the
Luxembourg Stock Exchange and to trading on the Luxembourg Stock Exchange's regulated market of the
Notes described herein issued pursuant to the Global Debt Issuance Facility of International Bank for
Reconstruction and Development.
RESPONSIBILITY
IBRD accepts responsibility for the information contained in these Final Terms.
Signed on behalf of IBRD:
By:
Name:
Title:
Duly authorized
-6-
DC_LAN01:383879.2

Document Outline

#5">Recent Developments